45.43000 USD
3.73
7.59%
Last update Dec 17, 3:59 PM EST
Market closed
Day range
44.34000
51.47000
Previous close
49.16000
Open
49.54000
Access this stock data via API
Subscribe
Nektar Therapeutics Inc.
45.43
3.73
7.59%

Analysis

Earnings estimate Current quarter
(Dec 2025)
Next quarter
(Mar 2026)
Current year
(Dec 2025)
Next year
(Dec 2026)
Number of analysts 1 1 1 2
Average estimate -2.90 -2.59 -7.97 -11.86
Low estimate -2.90 -2.59 -7.97 -12.12
High estimate -2.90 -2.59 -7.97 -11.60
Last year EPS -2.25 -3.61 -10.50 -7.97
Access /earnings_estimate data via our API — starting from the Ultra plan.
Revenue estimate Current quarter
(Dec 2025)
Next quarter
(Mar 2026)
Current year
(Dec 2025)
Next year
(Dec 2026)
Number of Analysts 7 5 7 7
Avg. estimate 10.92M 10.10M 44.34M 40.72M
Low estimate 6.90M 6M 40M 24M
High estimate 15.81M 12.50M 49.24M 54.44M
Last year sales 29.18M 10.46M 98.43M 44.34M
Sales growth -0.63 -0.03 -0.55 -0.08
Access /revenue_estimate data via our API — starting from the Ultra plan.
EPS trend Current quarter
(Dec 2025)
Next quarter
(Mar 2026)
Current year
(Dec 2025)
Next year
(Dec 2026)
Current estimate -2.90 -2.59 -7.97 -11.86
7 days ago -2.90 -2.59 0 -11.86
30 days ago -2.98 -3.10 0 -10.97
60 days ago -3.12 -3.10 -11.67 -12.02
90 days ago -3.12 -3.10 -11.67 -12.02
Access /eps_trend data via our API — starting from the Ultra plan.
EPS revisions Current quarter
(Dec 2025)
Next quarter
(Mar 2026)
Current year
(Dec 2025)
Next year
(Dec 2026)
Up last 7 days 1 1 1 1
Up last 30 days 1 1 1 2
Down last 7 days 0 0 0 0
Down last 30 days 1 0 0 0
Access /eps_revisions data via our API — starting from the Ultra plan.
Growth estimates
Current qtr (Dec 2025) -0.289%
Next qtr. (Mar 2026) 0.282%
Current year (2025) 0.241%
Next 5 years (per annum) -0.488%
Past 5 years (per annum) -0.489%
Access /growth_estimates data via our API — starting from the Ultra plan.

Recommendation

Access /recommendations data via our API — starting from the Ultra plan.

Analyst ratings

Firm Date Action
BTIG Dec 16, 2025 Maintains
HC Wainwright & Co. Dec 16, 2025 Maintains
Citigroup Nov 26, 2025 Initiates
Jefferies Nov 26, 2025 Maintains
B. Riley Securities Sep 23, 2025 Maintains
BTIG Sep 19, 2025 Reiterates
B. Riley Securities Jul 08, 2025 Maintains
HC Wainwright & Co. Jun 24, 2025 Maintains
Jefferies Apr 11, 2025 Upgrade
Oppenheimer Mar 14, 2025 Upgrade
HC Wainwright & Co. Mar 13, 2025 Reiterates
HC Wainwright & Co. Feb 25, 2025 Reiterates
HC Wainwright & Co. Jan 13, 2025 Reiterates
B. Riley Securities Jan 08, 2025 Initiates
Piper Sandler Nov 04, 2024 Initiates
BTIG Sep 30, 2024 Assumes
Jefferies Mar 06, 2024 Maintains
JP Morgan Nov 20, 2023 Reinstates
TD Cowen Nov 09, 2023 Upgrade
Mizuho Aug 07, 2023 Reiterates
Jefferies May 10, 2023 Upgrade
Oppenheimer Mar 06, 2023 Maintains
Goldman Sachs Feb 27, 2023 Maintains
SVB Leerink Feb 24, 2023 Maintains
Jefferies Feb 24, 2023 Downgrade
JP Morgan Aug 08, 2022 Downgrade
Jefferies May 31, 2022 Assumes
Mizuho Apr 18, 2022 Maintains
SVB Leerink Apr 18, 2022 Maintains
Goldman Sachs Apr 18, 2022 Downgrade
Access /analyst_ratings/light data via our API — starting from the Ultra plan.
Market closed

Exchange is currently closed
Pre-market opens in 5 hours 36 minutes

22:23
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).